Abstract
Upregulated of ANXA3, SORL1, and neutrophils may be a key factor in the progression of Ankylosing spondylitis.
Introduction
Ankylosing Spondylitis (AS) is a chronic inflammatory condition primarily affecting the axial skeleton, often resulting in significant structural damage and spinal fusion. While the association with the HLA-B27 variant is well-documented, the precise molecular mechanisms driving disease progression remain elusive. Recent research has highlighted the potential roles of hypoxia and immune cell infiltration in inflammatory joint diseases. This study investigates the intersection of hypoxia-related gene expression and immune profiling to identify novel diagnostic biomarkers and therapeutic targets for AS.
Methods
The study employed a multi-stage approach combining bioinformatics and clinical validation. Initially, two public microarray datasets (GSE25101 and GSE73754) from the Gene Expression Omnibus (GEO) were integrated, comprising 68 AS samples and 36 healthy controls. Differentially expressed genes (DEGs) were identified and intersected with 207 hypoxia-associated genes. Diagnostic candidates were further refined using Weighted Gene Co-Expression Network Analysis (WGCNA) and Support Vector Machine (SVM) modeling.
To validate these findings, the researchers analyzed interspinous ligament tissues from a local clinical cohort. This cohort included five AS patients undergoing spinal surgery and three control patients with intervertebral disc degeneration (IDD).
Immune profiling was conducted using CIBERSORT to estimate immune cell abundances from bulk RNA data. Finally, a large-scale validation was performed using routine blood test data from nearly 10,000 individuals to correlate gene expression with neutrophil counts and clinical disease activity scores (BASDAI).
Key Results
The bioinformatics screening identified ANXA3 and SORL1 as primary diagnostic biomarkers. ANXA3 is a member of the annexin family involved in inflammatory responses, while SORL1, traditionally linked to Alzheimer's disease, emerged as a novel player in AS pathogenesis.
ROC curve analysis confirmed the diagnostic utility of these markers, with ANXA3 and SORL1 achieving AUC values of 0.667 and 0.700, respectively. Immune profiling revealed a significant shift in the AS immune landscape, characterized by increased levels of activated NK cells and neutrophils, alongside decreased memory B cells and CD8 T cells.
Clinical validation supported these findings through several metrics:
- Neutrophil Correlation: Blood test data from 1,770 HLA-B27-positive cases showed significantly higher neutrophil counts compared to controls ($p < 0.001$).
- Disease Activity: Patients with high BASDAI scores exhibited significantly elevated neutrophil levels ($p < 0.001$), suggesting a link between neutrophil infiltration and disease severity.
- Protein Expression: Immunohistochemistry (IHC) confirmed that ANXA3 and SORL1 protein levels were significantly higher in AS spinal ligaments compared to controls ($p < 0.05$).
Discussion
The identification of SORL1 represents a significant shift in understanding AS, suggesting that pathways related to endolysosomal function or autophagy—previously associated with neurodegeneration—may also drive spinal inflammation. Furthermore, the strong correlation between ANXA3, SORL1, and neutrophil infiltration underscores the role of the hypoxic microenvironment in promoting oxidative stress and tissue damage. Neutrophils, acting as first responders, may exacerbate endothelial dysfunction and bone remodeling in the hypoxic niches of the spine.
Conclusion
This study identifies ANXA3 and SORL1 as key hypoxia-related biomarkers in Ankylosing Spondylitis. Their upregulation, coupled with increased neutrophil infiltration, appears to drive disease progression and clinical severity. While further functional studies are required to elucidate the exact mechanical pathways, these findings offer new diagnostic tools and potential avenues for targeted immunotherapy in AS.
Summary updated